Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shutong Granules
- Development stage
- Unknown
- Lead developer
- Beijing Derun Liuhe Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shutong Granules is a Traditional Chinese Medicine (TCM) developed by Beijing Derun Liuhe Pharmaceutical Technology Co., Ltd. specifically for the treatment of chronic pelvic inflammatory disease (CPID). The formulation is designed based on TCM principles to address the syndrome of Qi stagnation and blood stasis, which is commonly associated with persistent pelvic pain and inflammation in women. The drug consists of a proprietary blend of herbal extracts, including *Salvia miltiorrhiza* and *Cyperus rotundus*, which are traditionally used to promote blood circulation, resolve stasis, and alleviate pain. Clinical development in China has progressed through Phase 3 trials, focusing on the reduction of clinical symptoms such as lower abdominal pain, lumbosacral soreness, and inflammatory markers in patients with CPID.
- Brand names
- Shutong Granules
- Other names
- Shutong KeliShu-Tong Granules疏通颗粒
02
Targets
IL-6 (Interleukin 6)GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)EGFR T790M (Epidermal growth factor receptor T790M mutant)
Beyond the preview
Go deeper on Shutong Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shutong Granules.